Apteka Anna i Tomasz Przedniczeksp. j.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2002-02-11
Registered address
Warszawska 6, 26-900 Kozienice, Poland
Electronic delivery address
AE:PL-45908-76272-WITWU-21

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 57 days early.

  • 202526/06/2026
  • 202407/07/2025
  • 202310/06/2024
  • 202224/05/2023
  • 202118/05/2022
  • 202028/04/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 4.67mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 179.99kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 4.44mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 519.88kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apteka Anna i Tomasz Przedniczek has been an NFZ healthcare provider since 2024. In 2026 it is performing 1 contract worth USD 405.19. All its contracts were worth USD 856.89 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Pilot programmesłódzkie1USD 405.19

Ownership

Owner
Anna Maria Przedniczekage 63
Tomasz Zbigniew Przedniczekage 67

Manner of representation

Each partner is entitled to represent the company only jointly with another partner.

Anna Maria Przedniczek and Tomasz Zbigniew Przedniczek – all partners share the same surname, so the structure looks family-owned.

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 1993-07-05.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 1,693

Public aid

11 public aid cases recorded, with a total value of $166,165.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,406
De minimis aid (in accordance with Commission Regulation 2023/2831)
$1,403
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$1,895

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
DR ZdrowieS.A.
MagmaxS.A.
Adpharmasp. z o.o.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

FAQ

Last updated: 2026-06-29